281 related articles for article (PubMed ID: 19375969)
21. Comparison of Hemoglobin-based oxygen carriers to stored human red blood cells.
Eastman AL; Minei JP
Crit Care Clin; 2009 Apr; 25(2):303-10, Table of Contents. PubMed ID: 19341910
[TBL] [Abstract][Full Text] [Related]
22. Possible role of artificial oxygen carriers in transfusion medicine: a retrospective analysis on the current transfusion practice.
Yoshiba F; Kawaguchi AT; Hyodo O; Kinoue T; Inokuchi S; Kato S
Artif Organs; 2009 Feb; 33(2):127-32. PubMed ID: 19178456
[TBL] [Abstract][Full Text] [Related]
23. A review of methods used in comprehensive, descriptive studies that relate red blood cell transfusion to clinical data.
Biggin K; Warner P; Prescott R; McClelland B
Transfusion; 2010 Mar; 50(3):711-8. PubMed ID: 19929863
[TBL] [Abstract][Full Text] [Related]
24. From stem cells to red blood cells: how far away from the clinical application?
Xie X; Li Y; Pei X
Sci China Life Sci; 2014 Jun; 57(6):581-5. PubMed ID: 24829108
[TBL] [Abstract][Full Text] [Related]
25. An overview of unresolved inherent problems associated with red cell transfusion and potential use of artificial oxygen carriers and ECO-RBC: current status/future trends.
Seghatchian J; de Sousa G
Transfus Apher Sci; 2007 Dec; 37(3):251-9. PubMed ID: 18042438
[TBL] [Abstract][Full Text] [Related]
26. Blood cell manufacture: current methods and future challenges.
Timmins NE; Nielsen LK
Trends Biotechnol; 2009 Jul; 27(7):415-22. PubMed ID: 19500866
[TBL] [Abstract][Full Text] [Related]
27. Substitutes for red cell transfusion: 2000-2015 A.D.
Kim HW; Greenburg AG
Med Health R I; 1998 Dec; 81(12):400-5. PubMed ID: 9884540
[No Abstract] [Full Text] [Related]
28. Ex vivo generation of transfusable red blood cells from various stem cell sources: A concise revisit of where we are now.
Christaki EE; Politou M; Antonelou M; Athanasopoulos A; Simantirakis E; Seghatchian J; Vassilopoulos G
Transfus Apher Sci; 2019 Feb; 58(1):108-112. PubMed ID: 30616958
[TBL] [Abstract][Full Text] [Related]
29. Modeling transfusion reactions and predicting in vivo cell survival with kodecytes.
Oliver C; Blake D; Henry S
Transfusion; 2011 Aug; 51(8):1723-30. PubMed ID: 21303367
[TBL] [Abstract][Full Text] [Related]
30. A transient inflammatory reaction in the lung after experimental hemorrhagic shock and resuscitation with a hemoglobin-vesicles solution compared with rat RBC transfusion.
Yamanashi Y; Mori M; Terajima K; Tsueshita T; Horinouchi H; Sakai H; Sakamoto A
ASAIO J; 2009; 55(5):478-83. PubMed ID: 19625952
[TBL] [Abstract][Full Text] [Related]
31. Washing of stored red blood cells by an autotransfusion device before transfusion.
de Vroege R; Wildevuur WR; Muradin JA; Graves D; van Oeveren W
Vox Sang; 2007 Feb; 92(2):130-5. PubMed ID: 17298575
[TBL] [Abstract][Full Text] [Related]
32. In vitro production of red blood cells.
Mountford JC; Turner M
Transfus Apher Sci; 2011 Aug; 45(1):85-9. PubMed ID: 21723197
[TBL] [Abstract][Full Text] [Related]
33. Civilian uses of hemoglobin-based oxygen carriers.
Greenburg AG; Kim HW
Artif Organs; 2004 Sep; 28(9):795-9. PubMed ID: 15320942
[TBL] [Abstract][Full Text] [Related]
34. Red blood cell replacement, or nanobiotherapeutics with enhanced red blood cell functions?
Chang TM
Artif Cells Nanomed Biotechnol; 2015 Jun; 43(3):145-7. PubMed ID: 26096663
[TBL] [Abstract][Full Text] [Related]
35. Oxygen therapeutics: perfluorocarbons and blood substitute safety.
Cohn CS; Cushing MM
Crit Care Clin; 2009 Apr; 25(2):399-414, Table of Contents. PubMed ID: 19341916
[TBL] [Abstract][Full Text] [Related]
36. [Research advance on universal red blood cell engineering].
Tan YX; Ji SP; Gong F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):814-9. PubMed ID: 21729578
[TBL] [Abstract][Full Text] [Related]
37. [Production of mature red blood cell by using peripheral blood mononuclear cells].
Jia YJ; Liu J; Zhang KY; Shang XY; Li W; Wang LJ; Liu N; Wang L; Cui S; Ni L; Zhao BT; Wang DM; Gao SM; Zhang ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1435-41. PubMed ID: 25338603
[TBL] [Abstract][Full Text] [Related]
38. Low oxygen concentration as a general physiologic regulator of erythropoiesis beyond the EPO-related downstream tuning and a tool for the optimization of red blood cell production ex vivo.
Vlaski M; Lafarge X; Chevaleyre J; Duchez P; Boiron JM; Ivanovic Z
Exp Hematol; 2009 May; 37(5):573-84. PubMed ID: 19375648
[TBL] [Abstract][Full Text] [Related]
39. The hematopoietic stem cell niche: low in oxygen but a nice place to be.
Eliasson P; Jönsson JI
J Cell Physiol; 2010 Jan; 222(1):17-22. PubMed ID: 19725055
[TBL] [Abstract][Full Text] [Related]
40. Toward 21st century blood component replacement therapeutics: artificial oxygen carriers, platelet substitutes, recombinant clotting factors, and others.
Kim HW; Greenburg AG
Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):537-50. PubMed ID: 17090427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
